Casdin Private Growth Equity Fund, L.P. Insider Trading -- Recent SEC Form 4 Transactions

Casdin Private Growth Equity Fund, L.P. (CIK 1823061) reported 28 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-04). Recent activity: Buy LAB (125,000 shares), Buy LAB (75,000 shares), Buy LAB (150,000 shares), Buy LAB (7.5M shares), Buy LAB (150,000 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2025-12-04STANDARD BIOTOOLS INC. (LAB)DirectorBuy125,000$177,500
2025-12-04STANDARD BIOTOOLS INC. (LAB)DirectorBuy75,000$108,000
2025-12-04STANDARD BIOTOOLS INC. (LAB)DirectorBuy150,000$217,500
2025-11-26STANDARD BIOTOOLS INC. (LAB)DirectorBuy7.5M$9.8M
2025-11-26STANDARD BIOTOOLS INC. (LAB)DirectorBuy150,000$214,500
2025-11-20STANDARD BIOTOOLS INC. (LAB)DirectorBuy275,000$338,250
2025-11-20STANDARD BIOTOOLS INC. (LAB)DirectorBuy350,000$448,000
2025-11-20STANDARD BIOTOOLS INC. (LAB)DirectorBuy450,000$585,000
2025-11-17STANDARD BIOTOOLS INC. (LAB)DirectorBuy450,000$540,000
2025-11-17STANDARD BIOTOOLS INC. (LAB)DirectorBuy250,000$310,000
2025-11-17STANDARD BIOTOOLS INC. (LAB)DirectorBuy225,000$274,500
2025-11-12STANDARD BIOTOOLS INC. (LAB)DirectorBuy225,000$252,000
2025-11-12STANDARD BIOTOOLS INC. (LAB)DirectorBuy300,000$360,000
2025-11-12STANDARD BIOTOOLS INC. (LAB)DirectorBuy375,000$446,250
2025-11-12STANDARD BIOTOOLS INC. (LAB)DirectorBuy275,000$321,750
2025-09-11STANDARD BIOTOOLS INC. (LAB)DirectorBuy100,000$129,000
2025-09-05STANDARD BIOTOOLS INC. (LAB)DirectorBuy250,000$317,500
2025-09-05STANDARD BIOTOOLS INC. (LAB)DirectorBuy250,000$320,000
2025-08-26STANDARD BIOTOOLS INC. (LAB)DirectorBuy200,000$252,000
2025-08-26STANDARD BIOTOOLS INC. (LAB)DirectorBuy200,000$248,000
2025-08-26STANDARD BIOTOOLS INC. (LAB)DirectorBuy125,000$157,500
2025-08-15STANDARD BIOTOOLS INC. (LAB)DirectorBuy75,000$98,250
2025-08-15STANDARD BIOTOOLS INC. (LAB)DirectorBuy133,220$161,196
2025-08-15STANDARD BIOTOOLS INC. (LAB)DirectorBuy150,000$183,000
2025-03-04STANDARD BIOTOOLS INC. (LAB)DirectorBuy4.8M$5.2M

Source: SEC Form 4 filings · as of 2025-12-04